2020
DOI: 10.1107/s205698902000701x
|View full text |Cite
|
Sign up to set email alerts
|

1-Ethyl 2-methyl 3,4-bis(acetyloxy)pyrrolidine-1,2-dicarboxylate: crystal structure, Hirshfeld surface analysis and computational chemistry

Abstract: The title compound, C13H19NO8, is based on a tetra-substituted pyrrolidine ring, which has a twisted conformation about the central C—C bond; the Cm—Ca—Ca—Cme torsion angle is 38.26 (15)° [m = methylcarboxylate, a = acetyloxy and me = methylene]. While the N-bound ethylcarboxylate group occupies an equatorial position, the remaining substituents occupy axial positions. In the crystal, supramolecular double-layers are formed by weak methyl- and methylene-C—H...O(carbonyl) interactions involving all four carbony… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
4

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…The structure of the title tetra-substituted pyrrolidine derivative, (I), was determined in connection with our on-going structural studies characterizing key synthetic intermediates in the synthesis of various -glucosidase inhibitors (Zukerman-Schpector et al, 2017;Dallasta Pedroso et al, 2020). -Glucosidase inhibitors are an important class of drugs employed in the treatment of a variety of diseases such as cancer, cystic fibrosis, diabetes and influenza (Kiappes et al, 2018;Dhameja & Gupta, 2019).…”
Section: Chemical Contextmentioning
confidence: 99%
“…The structure of the title tetra-substituted pyrrolidine derivative, (I), was determined in connection with our on-going structural studies characterizing key synthetic intermediates in the synthesis of various -glucosidase inhibitors (Zukerman-Schpector et al, 2017;Dallasta Pedroso et al, 2020). -Glucosidase inhibitors are an important class of drugs employed in the treatment of a variety of diseases such as cancer, cystic fibrosis, diabetes and influenza (Kiappes et al, 2018;Dhameja & Gupta, 2019).…”
Section: Chemical Contextmentioning
confidence: 99%
“…data reports in this connection that the structure of the title tetra-substituted pyrrolidine derivative, (I), was determined in the context of supporting studies designed to provide conformational details of the molecular structures of crucial synthetic intermediates in the generation of various -glucosidase inhibitors (Zukerman-Schpector et al, 2017;Dallasta Pedroso et al, 2020a;Dallasta Pedroso et al, 2020b).…”
mentioning
confidence: 99%
“…The substitution pattern in pyrrolidine (I) is comparatively rare with the most closely related structures being only recently reported. In one derivative, the difference arises as the N1-bound substituent is a 4-nitrophenylmethyl group while the other groups are the same (Dallasta Pedroso et al, 2020a) while in the other, only the substituent at the C4 differs, with the literature structure having a methylcarboxylate group (Dallasta Pedroso et al, 2020b).…”
mentioning
confidence: 99%